|
Jun 26
|
Semler Scientific Trades at Premium to Bitcoin Holdings for First Time in Three Weeks
|
|
Jun 24
|
Pompliano’s ProCap Buys 3,724 Bitcoin After Raising $750M War Chest
|
|
Jun 24
|
Semler Scientific® Announces CardioVanta™, a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities
|
|
Apr 30
|
Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 2025 Financial Results
|
|
Apr 23
|
Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today
|
|
Feb 20
|
Undiscovered Gems in United States Stocks for February 2025
|
|
Feb 19
|
Semler Scientific Inc (SMLR) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
|
|
Feb 18
|
Semler Scientific® Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC
|
|
Feb 18
|
Are Semler Scientific, Inc.'s (NASDAQ:SMLR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|
|
Dec 31
|
Undervalued Small Caps With Insider Action In US For December 2024
|
|
Sep 30
|
Semler Scientific (NASDAQ:SMLR) shareholders have endured a 81% loss from investing in the stock three years ago
|
|
Aug 7
|
Semler Scientific Second Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.88 in 2Q 2023)
|
|
Aug 5
|
Semler Scientific® Reports Second Quarter 2024 Financial Results and Additional Bitcoin Purchases
|
|
Apr 9
|
Semler Scientific (NASDAQ:SMLR) investors are sitting on a loss of 74% if they invested three years ago
|
|
Feb 19
|
Semler Scientific (SMLR) Benefited from the Continued Growth of QuantaFlo for PAD Testing
|
|
Jan 5
|
Why Semler Scientific, Inc. (NASDAQ:SMLR) Could Be Worth Watching
|
|
Dec 2
|
A Look At The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
|
|
May 1
|
Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
|
|
Apr 28
|
Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
|